Businesses often promote workplace diversity to investors as a key performance driver. But a new report from responsible investing leader Regnan finds diversity strategies mean little without a focus on equity and inclusion.
Latest reflections from the JOHCM Global Opportunities team.
Five indicators to monitor risk and opportunity from the JOHCM Global Emerging Markets Opportunities team.
An update from the JOHCM UK Dynamic team in a quarter that saw frenzied bid activity for a number of portfolio holdings.
The JOHCM UK Opportunities team discuss four new investments and how each can grow their respective cash flows in four very different markets.
Samir Mehta takes a look at the three cross-currents affecting Chinese technology stocks.
June was an odd month with bond yields under pressure before and after the FOMC meeting despite positive economic data and company commentary.
Ten inflation protection strategies for income investors from the JOHCM Global Income Builder team
Quarantine musings from Samir Mehta, manager of the JOHCM Asia ex Japan Fund.
Mark Costar and Vishal Bhatia discuss why the Fund is seeing plenty of M&A activity and describe why they are backing companies that back themselves.
Portfolio positioning around the commodity rally: the JOHCM Global Emerging Markets Opportunities team provide an update
Increasing signs the market is beginning to recognise the undervaluation of some of the Fund’s holdings was aided by another period of strong earnings updates in May.
Samir Mehta reviews his position on banks as rising expectations of inflation, long bond yields and commodity prices dominate market headlines.
Continued strong economic prints, rising commodity prices, increased inflationary expectations and steepening yield curves were all features in May.
Many income funds continue to lean on stocks with poor ESG properties and risks - it doesn't have to be this way...
The pick-up in capital flows, higher commodity prices and vaccination roll-outs are powerful drivers for commodity-exporting emerging markets.
A monthly roundup from the JOHCM UK Dynamic team in a month where markets were buoyed by extraordinarily strong economic data.
In light of the recent universal bullishness, is it time for some caution?
Clive and James discuss the macro and the micro, from global economics to new portfolio additions and whether the ‘vaccine value rally’ can continue.
With Covid-19 case numbers rising rapidly, James Syme reviews the portfolio's Indian exposure.
In their latest update, Rachel Reutter and Michael Ulrich focus on four topics that have been dominating their thoughts and actions over the last quarter.
Alex and Tom provide an update on a strong quarter for the portfolio as operating performance and share price momentum continued to build.
The current debate on incipient inflation is the elephant in the room. Samir Mehta provides his thoughts.
10 things we are thinking about for the rate regime that may lie ahead.
James and Clive on why the shift in stock market leadership towards 'value' has much further to run.
A look at the investment landscape in Europe and the key areas where we are finding opportunities.
A top-down look at Brazil from the JOHCM Global Emerging Markets Opportunities team.
Investor confidence grew in February as Covid-19 vaccination roll-outs accelerated. Alex and Tom provide a portfolio update.
Markets have changed dramatically; we have democratised access to trading across age groups and income levels. Samir looks at the ramifications
James and Clive's latest portfolio review covering February, a month which saw a sharp rise in government bond yields.
For a better experience, we recommend viewing this website in landscape orientation.